Omar
@dromar.eth
Factor hitting hard with the GLP-1 included campaign
2 replies
0 recast
3 reactions
SB
@farmerboy
United States spends the most on GLP-1 advertising. This is primarily because direct-to-consumer pharmaceutical advertising (DTCA) is only legal in the US and New Zealand, and the US market is by far the largest and most active in this space. In 2023, GLP-1 drug advertising spend in the US topped $1 billion, with the majority of this spending focused on diabetes and weight loss drugs such as Ozempic, Wegovy, and Mounjaro. Major pharmaceutical companies like Novo Nordisk and Eli Lilly are the leading spenders, with TV advertising alone for GLP-1 drugs in the US exceeding $400 million in the past year. 🙈🙈🙈💰💰💰💰it’s a cosmetic product for business not services real humanity and helping people. All about business
0 reply
0 recast
0 reaction
SB
@farmerboy
To me GLP-1 Is a cosmetic product for group of people rather solving problems. Any great products should be available and solve social problems. GLP-1 And similar products are just marketing to sell faster among certain people and companies to make billions faster faster . We will see many other quick packages program using similar drugs and business models around it in USA . USA is a country of broker and brokerages appear with great ideas and die faster until true benefits emerge in different ways. top twenty countries with the highest adult obesity rates (percentage of adults with BMI ≥ 30) are: 1. Samoa – 81.48% 2. Nauru – 74.97% 3. Tonga – 74.48% 4. Tuvalu – 69.25% 5. Saint Kitts and Nevis – 54.54% 6. The Bahamas – 51.69% 7. Marshall Islands – 51.46% 8. Kiribati – 51.42% 9. Micronesia – 51.31% 10. Qatar – 50.7% 11. Kuwait – 50.14% 12. Palau – 47.22% 13. Egypt – 46.46% 14. Saudi Arabia – 46.41% 15. Belize – 46.33% 16. United States – 45.58% 17. Bahrain – 44.53% 18. Barbados – 44.3% 19. Antigua and Barbuda – 44.25% 20. Chile – 43.6% 😂😂😂😂😂drugs company footage in every inch in USA then all over world due to consumer nature here, credit borrowing society or consumers are lucrative for all drugs selling companies and intermediate level business
0 reply
0 recast
0 reaction
